Platinum Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 24-12-2024
- Paid Up Capital ₹ 1.81 Cr
as on 24-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 3.60 Cr
as on 24-12-2024
About Platinum Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.81 Cr.
The company currently has active open charges totaling ₹3.60 Cr.
Suman Jaitly, Amit Jaitly, Anil Jaitly, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233DL2005PTC140315
- Company No.
140315
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2005
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Platinum Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suman Jaitly  | Director | 02-Apr-2011 | Current |
| Amit Jaitly | Director | 02-Apr-2011 | Current |
| Anil Jaitly | Director | 02-Apr-2011 | Current |
| Amit Chawla | Director | 02-Sep-2005 | Current |
Financial Performance of Platinum Pharmaceuticals.
Enhance accessibility to Platinum Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Platinum Pharmaceuticals?
Unlock access to Platinum Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Link Infratech Private LimitedActive 15 years 7 monthsSuman Jaitly, Amit Jaitly and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 24 Aug 2009 | ₹5.00 M | Open |
Punjab National Bank Creation Date: 29 Mar 2007 | ₹3.00 M | Open |
Punjab National Bank Creation Date: 03 Aug 2006 | ₹1.35 Cr | Open |
How Many Employees Work at Platinum Pharmaceuticals?
Unlock and access historical data on people associated with Platinum Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Platinum Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Platinum Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
